ACROBiosystems unveils four-day antibody validation service for AI-driven drug discovery

Verifying
  • ACROBiosystems launched ACRO AIx, CHO-Direct and GlobalLifeShip for AI-driven drug discovery.
  • Four days is the stated minimum turnaround from antibody sequence submission to affinity data.
  • ACRO AIx includes products, tools, validation and data connections; GlobalLifeShip offers cross-border logistics.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.